Last reviewed · How we verify
Pharmacokinetic Pilot Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers, Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler: A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects
The aim of the study is to assess and compare the Pharmacokinetic (PK) of Budesonide and Formoterol after administration of 3 different product variants of Budesonide/Formoterol Easyhalers and Symbicort turbuhaler.
Details
| Lead sponsor | Orion Corporation, Orion Pharma |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 17 |
| Start date | 2011-10 |
| Completion | 2011-12 |
Conditions
- Healthy
Interventions
- Budesonide
- Formoterol
- Easyhaler
- Turbohaler Forte
Primary outcomes
- Cmax of Budesonide and Formoterol — 24 hours
- AUCt of Budesonide and Formoterol — 24 hours
Countries
Germany